Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies

JP De Aquino, A Bahji, O Gómez, M Sofuoglu - Drug and alcohol …, 2022 - Elsevier
Background While six US states have already officially authorized cannabinoids to substitute
opioids and treat opioid use disorder, the therapeutic benefits of cannabinoids remain …

The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review

S Lake, MS Pierre - Clinical Psychology Review, 2020 - Elsevier
Despite high rates of cannabis use during medication-based treatment of opioid use
disorder (MOUD), uncertainty remains around how cannabis influences treatment outcomes …

The case for a medication first approach to the treatment of opioid use disorder

RP Winograd, N Presnall, E Stringfellow… - The American Journal …, 2019 - Taylor & Francis
Background: The opioid addiction and overdose crisis continues to ravage communities
across the US Maintenance pharmacotherapy using buprenorphine or methadone is the …

“I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums

MC Meacham, AL Nobles, DA Tompkins, J Thrul - PloS one, 2022 - journals.plos.org
A growing body of research has reported on the potential opioid-sparing effects of cannabis
and cannabinoids, but less is known about specific mechanisms. The present research …

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

T Rosic, R Kapoor, B Panesar, L Naji, DB Chai… - Harm reduction …, 2021 - Springer
Background With the ongoing opioid crisis and policy changes regarding legalization of
cannabis occurring around the world, it is necessary to consider cannabis use in the context …

Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial

P Goyal, D Kattula, R Rao, R Bhad, AK Mishra… - Drug and Alcohol …, 2023 - Elsevier
Background Sleep disturbances are seen even in individuals on opioid agonist treatment
(OAT). Established pharmacotherapy for sleep disturbances such as benzodiazepines have …

A review of historical context and current research on cannabis use in India

P Karki, M Rangaswamy - Indian Journal of Psychological …, 2023 - journals.sagepub.com
Background: The cultivation and use of cannabis is historically rooted in the Indian
subcontinent and this rich heritage of cannabis use dates back to at least two thousand …

What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review

G Campbell, W Hall, S Nielsen - International Review of Psychiatry, 2018 - Taylor & Francis
Pre-clinical research supports that cannabinoids reduce opioid dose requirements, but few
studies have tested this in humans. This review evaluates ecological and epidemiological …

The cannabis-dependent relationship between methadone treatment dose and illicit opioid use in a community-based cohort of people who use drugs

S Lake, T Kerr, J Buxton, Z Walsh… - Cannabis and …, 2023 - liebertpub.com
Background: Methadone maintenance treatment (MMT) is an effective treatment for opioid
use disorder. However, subtherapeutic dosing may lead to continued opioid use by failing to …

Research on opioid substitution therapy in India: A brief, narrative review

A Ambekar, R Rao, A Agrawal… - Indian journal of …, 2018 - journals.lww.com
Opioid dependence is a significant clinical and public health issue in India. Opioid
substitution therapy (OST) is the most evidence-based treatment for opioid dependence …